Serum C-reactive protein predicts poor prognosis in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy

Por Zeng, Y.C., Wu, R., Xiao, Y.P., Chi, F., Xue, M., Zhang, Z.Y., Xing, R., Zhong, W.Z., Wang, S.L., Tian, X., Chen, W., Chen, J.J., Wu, L.N.
Publicado no Curr Oncol (2015)